You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: January 6, 2025

Drug Price Trends for ORACIT ORAL SOLUTION


✉ Email this page to a colleague

« Back to Dashboard


Drug Price Trends for ORACIT ORAL SOLUTION

Average Pharmacy Cost for ORACIT ORAL SOLUTION

These are average pharmacy acquisition costs (net of discounts) from a US national survey
Drug Name NDC Price/Unit ($) Unit Date
ORACIT ORAL SOLUTION 46287-0014-01 0.08075 ML 2024-12-18
>Drug Name >NDC >Price/Unit ($) >Unit >Date

ORACIT ORAL SOLUTION Market Analysis and Financial Projection

Oracit Oral Solution: Market Analysis and Price Projections

Market Definition and Use

Oracit oral solution, which contains citric acid and sodium citrate, is primarily used for urinary alkalinization and the treatment of urinary tract stones. It works by increasing the pH of the urine, making it less acidic and helping to dissolve kidney stones or reduce their formation[2].

Market Size and Growth

While specific market size data for Oracit alone is not readily available, the broader market for oral electrolyte solutions and oral rehydration solutions provides context for the potential growth and demand.

  • The global oral electrolyte solutions market, which includes products like Oracit, is projected to grow at a CAGR of 13% from 2022 to 2029, reaching USD 27 billion by 2029. This growth is driven by increasing cases of diarrhea, vomiting, and other conditions that lead to electrolyte loss[1].

  • The oral rehydration solution (ORS) market, another related segment, is anticipated to reach USD 6.71 billion by 2031, expanding at a 9.9% CAGR from 2022 to 2031. This growth is fueled by global health initiatives aimed at reducing child mortality rates due to diarrhea and dehydration[4].

Drivers of Market Growth

Several factors contribute to the growth of the market for oral electrolyte solutions like Oracit:

  • Increasing Prevalence of Diarrheal Diseases: Diarrhea remains a significant cause of mortality, especially among children. According to the Global Burden of Disease, diarrheal disease caused the deaths of more than half a million children in 2017. This drives the demand for oral electrolyte solutions[1].

  • Changing Lifestyle and Increased Health Awareness: The rising disposable income and changing lifestyles of consumers lead to increased spending on ready-to-consume health products, including oral electrolyte solutions. Growing health awareness also contributes to the market's growth[1].

  • Government and Global Health Initiatives: Organizations like the WHO and UNICEF are actively promoting the use of oral rehydration solutions in developing countries to reduce child mortality rates due to diarrhea and dehydration. These initiatives boost the market for related products like Oracit[4].

Market Segmentation

The market for oral electrolyte solutions, including Oracit, can be segmented in several ways:

  • By Type: Different formulations such as citric acid and sodium citrate solutions.
  • By Indication: Urinary alkalinization, urinary tract stones, and other specific uses.
  • By Application: Pediatric, adult, and geriatric use.
  • By End-Users: Hospitals, homecare, specialty clinics, and others.
  • By Distribution Channel: Hospital pharmacy, online pharmacy, retail pharmacy[1].

Pricing and Cost Analysis

The pricing of Oracit oral solution can vary based on several factors including the quantity, strength, and distribution channel.

  • Current Pricing: For example, a 1500 mL quantity of Oracit with a strength of 640 mg-490 mg/5 mL can cost around $341.20, which translates to approximately $0.23 per unit[2].

  • Cost Considerations: The high cost of some oral electrolyte solutions can be a restraint for market growth. However, the availability of generic alternatives and increasing demand through retail pharmacies can help mitigate these costs[1].

Opportunities and Challenges

Opportunities

  • Increased Product Launches: Innovations such as pediatric electrolyte oral thin-film strips can create new opportunities for market growth. For instance, Pace Wellness's Solves strips are designed for children to quickly replenish electrolytes[1].

  • Growing Demand for Retail Pharmacies: The rise in the number of retail pharmacies and patient preference for these outlets can increase the accessibility and sales of oral electrolyte solutions[1].

Challenges

  • Lack of Skilled Professionals: The lack of qualified personnel to administer these solutions can curb market growth.
  • High Cost: The high cost of some oral electrolyte solutions can be a barrier to adoption, especially in developing countries[1].

Regional Outlook

The market for oral electrolyte solutions, including Oracit, varies by region:

  • North America: Expected to be a leading region due to the presence of key manufacturers and a well-developed healthcare infrastructure[4].

  • Asia Pacific: Anticipated to expand significantly due to high investment in children’s healthcare programs and focus on malnutrition among children in countries like India[4].

Key Takeaways

  • The global oral electrolyte solutions market, which includes products like Oracit, is expected to grow significantly due to increasing cases of diarrhea and vomiting.
  • Government and global health initiatives play a crucial role in promoting the use of oral rehydration solutions.
  • The market is segmented by type, indication, application, end-users, and distribution channels.
  • High cost and lack of skilled professionals are significant challenges.
  • North America and the Asia Pacific are key regions driving market growth.

FAQs

1. What is Oracit oral solution used for? Oracit oral solution is primarily used for urinary alkalinization and the treatment of urinary tract stones by increasing the pH of the urine.

2. How is the market for oral electrolyte solutions expected to grow? The global oral electrolyte solutions market is projected to grow at a CAGR of 13% from 2022 to 2029, reaching USD 27 billion by 2029.

3. What are the main drivers of the market growth for oral electrolyte solutions? The main drivers include increasing cases of diarrhea, changing lifestyles, and growing health awareness, as well as government and global health initiatives.

4. What are the challenges facing the market for oral electrolyte solutions? The challenges include the lack of skilled professionals and the high cost of some oral electrolyte solutions.

5. Which regions are expected to lead the market growth for oral electrolyte solutions? North America and the Asia Pacific are expected to be the leading regions due to the presence of key manufacturers and significant investments in healthcare programs.

Sources

  1. Data Bridge Market Research - Global Oral Electrolyte Solutions Market Size, Research Report, & Industry Trends and Forecast to 2029.
  2. Drugs.com - Oracit Alternatives Compared.
  3. Globenewswire - Oral Rehydration Solution (ORS) Market to Exceed USD 6.71 billion by 2031.
  4. Transparency Market Research Inc. - Oral Rehydration Solution (ORS) Market to Exceed USD 6.71 billion by 2031.
  5. Memorial Sloan Kettering - Sodium Citrate and Citric Acid: Pediatric Medication.

More… ↓

⤷  Subscribe

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.